Literature DB >> 30073622

CD163+ macrophages infiltrate axon bundles of postmortem optic nerves with glaucoma.

Milica A Margeta1, Eleonora M Lad2, Alan D Proia2,3.   

Abstract

PURPOSE: Prior research in animal models has shown that macrophages and microglia play an important role in pathogenesis of glaucoma, but the phenotype and distribution of macrophages in human glaucomatous tissue have not been sufficiently characterized.
METHODS: We analyzed H&E, CD68-, and CD163-immunostained slides from 25 formaldehyde-fixed, paraffin-embedded autopsy eyes: 12 control eyes and 13 eyes with glaucoma. The diagnosis of glaucoma was made based on a history of glaucoma as reported in the medical record and histological changes characteristic of glaucoma. Glaucoma cases and controls were matched in terms of age, sex, and race.
RESULTS: Qualitative analysis of the conventional outflow pathway and the optic nerve revealed that all eyes contained CD163+ cells but a negligible number of CD68+ cells. CD163+ macrophages infiltrated the trabecular meshwork and surrounded Schlemm's canal of normal eyes and eyes with glaucoma, but the pattern was variable and qualitatively similar between groups. In optic nerves of control eyes, CD163+ macrophages were present at low levels and restricted to septa between axon bundles. In glaucomatous optic nerves, the number of CD163+ cells was increased both qualitatively and quantitatively (glaucoma 5.1 ± 0.6 CD163+ cells/mm2, control 2.5 ± 0.3 CD163+ cells/mm2, p < 0.001), with CD163+ cells infiltrating axon bundles in cases of both mild and severe diseases.
CONCLUSIONS: The increase in CD163+ cell number in eyes with mild and severe glaucoma is the first demonstration of macrophage infiltration in glaucomatous human optic nerves. This finding supports a role for macrophages in glaucoma pathogenesis and progression.

Entities:  

Keywords:  Glaucoma; Macrophages; Microglia; Neurodegeneration; Neuroprotection; Optic nerve

Mesh:

Substances:

Year:  2018        PMID: 30073622      PMCID: PMC6221945          DOI: 10.1007/s00417-018-4081-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

1.  Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163).

Authors:  P Högger; J Dreier; A Droste; F Buck; C Sorg
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

Review 2.  Neuroinflammation in glaucoma: A new opportunity.

Authors:  Pete A Williams; Nick Marsh-Armstrong; Gareth R Howell
Journal:  Exp Eye Res       Date:  2017-02-24       Impact factor: 3.467

3.  Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma.

Authors:  A H Neufeld
Journal:  Arch Ophthalmol       Date:  1999-08

Review 4.  Changes in macrophage phenotype as the immune response evolves.

Authors:  Julia Lichtnekert; Takahisa Kawakami; William C Parks; Jeremy S Duffield
Journal:  Curr Opin Pharmacol       Date:  2013-06-07       Impact factor: 5.547

5.  Early microglia activation in a mouse model of chronic glaucoma.

Authors:  Alejandra Bosco; Michael R Steele; Monica L Vetter
Journal:  J Comp Neurol       Date:  2011-03-01       Impact factor: 3.215

6.  Visual Field Progression is Associated with Systemic Concentration of Macrophage Chemoattractant Protein-1 in Normal-Tension Glaucoma.

Authors:  Na Young Lee; Min Hee Kim; Chan Kee Park
Journal:  Curr Eye Res       Date:  2017-03-17       Impact factor: 2.424

Review 7.  The complex role of neuroinflammation in glaucoma.

Authors:  Ileana Soto; Gareth R Howell
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-03       Impact factor: 6.915

8.  TMEM119 marks a subset of microglia in the human brain.

Authors:  Jun-ichi Satoh; Yoshihiro Kino; Naohiro Asahina; Mika Takitani; Junko Miyoshi; Tsuyoshi Ishida; Yuko Saito
Journal:  Neuropathology       Date:  2015-08-06       Impact factor: 1.906

9.  Evidence Supporting an Association Between Expression of Major Histocompatibility Complex II by Microglia and Optic Nerve Degeneration During Experimental Glaucoma.

Authors:  Glyn Chidlow; Andreas Ebneter; John P M Wood; Robert J Casson
Journal:  J Glaucoma       Date:  2016-08       Impact factor: 2.503

10.  Neurodegeneration severity can be predicted from early microglia alterations monitored in vivo in a mouse model of chronic glaucoma.

Authors:  Alejandra Bosco; Cesar O Romero; Kevin T Breen; Alexis A Chagovetz; Michael R Steele; Balamurali K Ambati; Monica L Vetter
Journal:  Dis Model Mech       Date:  2015-03-09       Impact factor: 5.758

View more
  14 in total

1.  Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis.

Authors:  Tavé van Zyl; Wenjun Yan; Alexi McAdams; Yi-Rong Peng; Karthik Shekhar; Aviv Regev; Dejan Juric; Joshua R Sanes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-27       Impact factor: 11.205

2.  Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma.

Authors:  Milica A Margeta; Zhuoran Yin; Charlotte Madore; Kristen M Pitts; Sophia M Letcher; Jing Tang; Shuhong Jiang; Christian D Gauthier; Sebastian R Silveira; Caitlin M Schroeder; Eleonora M Lad; Alan D Proia; Rudolph E Tanzi; David M Holtzman; Susanne Krasemann; Dong Feng Chen; Oleg Butovsky
Journal:  Immunity       Date:  2022-08-16       Impact factor: 43.474

3.  Optic Nerve Head Myelin-Related Protein, GFAP, and Iba1 Alterations in Non-Human Primates With Early to Moderate Experimental Glaucoma.

Authors:  Priya Chaudhary; Cheri Stowell; Juan Reynaud; Stuart K Gardiner; Hongli Yang; Galen Williams; Imee Williams; Nicholas Marsh-Armstrong; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-10-03       Impact factor: 4.925

Review 4.  The vital role for nitric oxide in intraocular pressure homeostasis.

Authors:  Ester Reina-Torres; Michael L De Ieso; Louis R Pasquale; Michael Madekurozwa; Joseph van Batenburg-Sherwood; Darryl R Overby; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2020-11-28       Impact factor: 21.198

Review 5.  Myeloid cells in retinal and brain degeneration.

Authors:  Michelle Guo; Turner D Schwartz; Joshua L Dunaief; Qi N Cui
Journal:  FEBS J       Date:  2021-09-15       Impact factor: 5.622

6.  Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma.

Authors:  Pete A Williams; Catherine E Braine; Krishnakumar Kizhatil; Nicole E Foxworth; Nicholas G Tolman; Jeffrey M Harder; Rebecca A Scott; Gregory L Sousa; Alyssa Panitch; Gareth R Howell; Simon W M John
Journal:  Mol Neurodegener       Date:  2019-01-22       Impact factor: 14.195

7.  Comorbidity of age-related macular degeneration with Alzheimer's disease: A histopathologic case-control study.

Authors:  Gordon J Smilnak; John R Deans; P Murali Doraiswamy; Sandra Stinnett; Heather E Whitson; Eleonora M Lad
Journal:  PLoS One       Date:  2019-09-30       Impact factor: 3.240

8.  The Innate Immune Cell Profile of the Cornea Predicts the Onset of Ocular Surface Inflammatory Disorders.

Authors:  Amaya Pérez Del Palomar; Alberto Montolío; José Cegoñino; Sandeep Kumar Dhanda; Chit Tong Lio; Tanima Bose
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

9.  Association of APOE With Primary Open-Angle Glaucoma Suggests a Protective Effect for APOE ε4.

Authors:  Milica A Margeta; Sophia M Letcher; Robert P Igo; Jessica N Cooke Bailey; Louis R Pasquale; Jonathan L Haines; Oleg Butovsky; Janey L Wiggs
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

10.  GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension.

Authors:  Jacob K Sterling; Modupe O Adetunji; Samyuktha Guttha; Albert R Bargoud; Katherine E Uyhazi; Ahmara G Ross; Joshua L Dunaief; Qi N Cui
Journal:  Cell Rep       Date:  2020-11-03       Impact factor: 9.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.